ASPIRUS WAUSAU HOSPITAL — History
CCN 520030 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$646M
Latest Revenue (FY2022)
+3.2%
Revenue CAGR (3yr)
3.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $606M | $645M | $646M | +0.0% | +3.2% |
| Operating Expenses | $567M | $628M | $626M | -0.3% | +5.1% |
| Operating Margin | 6.5% | 2.8% | 3.1% | +12.1% | -30.8% |
| Net Income | $39M | $18M | $20M | +12.2% | -28.6% |
| Licensed Beds | 236 | 210 | 239 | +13.8% | +0.6% |
| Total Patient Days | 62,428 | 71,180 | 66,009 | -7.3% | +2.8% |
| Medicare Day % | 32% | 28% | 33% | +17.0% | +1.8% |
| Medicaid Day % | 5% | 6% | 7% | +35.2% | +22.6% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +6.6% ($606M → $646M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+3.2%
This Hospital
+7.6%
State Avg
Latest Margin
3.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $666M | 1.4% |
| FY2024 (proj) | $686M | -0.3% |
| FY2025 (proj) | $705M | -2.0% |